HRMY NASDAQ
Harmony Biosciences Holdings, Inc.
1W: -0.8%
1M: +4.4%
3M: +17.9%
YTD: +11.1%
1Y: +25.0%
3Y: +13.3%
5Y: +18.6%
$41.52
+0.42 (+1.02%)
Weekly Expected Move ±4.8%
$38
$40
$42
$44
$46
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.4B
52W Range25.52-43.49
Volume973,307
Avg Volume818,971
Beta0.93
Dividend—
Analyst Ratings
Company Info
CEOJeffrey Dayno
Employees293
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-19
Websiteharmonybiosciences.com
630 West Germantown Pike
Plymouth Meeting, PA 19462
US
Plymouth Meeting, PA 19462
US
484 539 9800
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
Latest News
Ten healthcare stocks with A-rated valuations and strong revenue growth
Legal & General Group Plc Invests $3.50 Million in Harmony Biosciences Holdings, Inc. $HRMY
Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Budur Kumar | S-Sale | 4,500 | $42.25 | 2026-09-08 |
| Budur Kumar | S-Sale | 1,000 | $42.79 | 2026-09-08 |
| Budur Kumar | M-Exempt | 12,200 | $30.69 | 2026-09-08 |
| Budur Kumar | M-Exempt | 10,754 | $30.27 | 2026-09-08 |
| Budur Kumar | S-Sale | 22,954 | $43.10 | 2026-09-08 |